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Sir,
The recent identiﬁcation of the ﬁrst plasmid-mediated polymyxin
resistance determinants, namely the MCR-1 and MCR-2 enzymes,
has constituted an ultimate threat of pandrug resistance in Gram-
negative organisms.1–3 These enzymes have been reported only in
Enterobacteriaceae, mainly in Escherichia coli and Klebsiella pneu-
moniae; however, there have been reports from other enterobac-
terial genera, including Enterobacter, Salmonella and Shigella.1 The
mcr-1 and mcr-2 genes have both been identiﬁed from cattle
and pigs.1–3 In addition, the mcr-1 gene has been identiﬁed from
chickens,4 but also from river samples and vegetables.5
MCR-1 and MCR-2, sharing 81% amino acid identity, are phos-
phoethanolamine transferases of 541 and 538 amino acids, re-
spectively.2,3 They add phosphoethanolamine to the lipid Amoiety
of LPS, leading to a more cationic LPS structure and consequently
to resistance to polymyxins.1
We recently showed that some Moraxella species might consti-
tute putative reservoirs of MCR-like proteins, with corresponding
genes located on the chromosome of these species.6 Hence, MCR-
like proteins were identiﬁed in Moraxella catarrhalis, Moraxella
lincolnii, Moraxella porci and Moraxella osloensis. They all share sig-
niﬁcant amino acid identities with MCR-1 and MCR-2, ranging from
59% to 64%.6 Even though these Moraxella species have been
shown to carry intrinsic mcr-like genes, these genes remain quite
distantly related to the plasmid-bornemcr-1 andmcr-2.
We recently had the opportunity to investigate another
Moraxella species. Moraxella pluranimalium strain 248-01T
has been isolated from the nasal turbinate of a healthy pig
in Spain.7 M. pluranimalium is an aerobic and catalase- and
oxidase-positive Gram-negative coccus that grows at temperatures
of 22–37C.7
PCR assays with internal primers speciﬁc for both mcr-1 and
mcr-2, as published,1 allowed us to obtain an amplicon that was
further sequenced. Internal outward primers were then designed
and used for an inverse PCR strategy, as previously performed.6
The sequence of the entiremcr gene was thus obtained and it re-
vealed that this new enzyme (termedMCR-2.2) was almost identi-
cal to MCR-2 (99% amino acid identity), with only 8 amino acid
differences out of the 538 constituting the MCR-2 enzyme, and
shared 82%amino acid identitywithMCR-1.
Interestingly, the mcr-2.2 gene exhibits a G!C content of
49.1%, which is in accordance with the total G!C content of the
genomes of differentMoraxella species (45%),which agreeswith
the intrinsic origin of this gene inM. pluranimalium.
The corresponding gene, namedmcr-2.2, was cloned into plas-
mid pBADb, the recombinant plasmid being then expressed in
E. coli TOP10 by adding L-arabinose 1% (necessary for the expres-
sion of the cloned genes in this inducible vector), as performed
for other mcr-like genes.6 Then MICs of colistin were determined
for the recombinant strains expressing mcr-1, mcr-2 and mcr-2.2
by broth microdilution (BMD),1 and this showed that MCR-2.2 con-
ferred exactly the same level of resistance as MCR-1 and MCR-2
(MIC 4mg/L compared with 0.03mg/L for the E. coli WT recipient
strain), thus showing that the few differences in terms of amino
acid sequence did not have an impact on resistance to colistin in
E. coli.
Interestingly, the MIC of colistin determined by BMD forM. plur-
animalium strain 248-01 was high (16mg/L). Susceptibility to
other antibiotics, determined by disc diffusion, showed that this
strain had a penicillinase phenotype, with resistance to amoxicillin
and ticarcillin removed by clavulanic acid. In addition, it was resist-
ant to tetracycline, nalidixic acid and ciproﬂoxacin, but remained
susceptible to all aminoglycosides, sulphonamides, chlorampheni-
col and fosfomycin.
Since themcr-1 andmcr-2 genes are often identiﬁed on IncX4-
type plasmid scaffolds, strain 248-01 was tested for the corres-
ponding replicase gene as reported,8 but it remained negative.
No plasmid could be identiﬁed despite several extraction attempts
and attempts to transfer a polymyxin resistance determinant by
electro-transformation into an E. coli recipient strain also failed.8
These negative results further suggest a chromosomal location of
the mcr-2.2 gene. Since the mcr-1 gene is most often associated
with the ISApl1 element, which has been shown to be involved in
its acquisition,9 and since IS1595 was found to be closely associ-
ated withmcr-2 (even though its involvement in the acquisition of
the resistance gene has not yet been proven),3 PCR speciﬁc for
those IS elements was performed using DNA from strain 248-01T
as a template. Interestingly, positive signals were obtained for
both ISs and sequencing conﬁrmed a perfect identity with ISApl1
and a variant of IS1595 (97% nucleotide identity), respectively.
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However, PCR mapping showed that these ISs were not located
upstream of themcr-2.2 gene, in contrast towhat is observedwith
both mcr-1 and mcr-2 genes when identiﬁed in enterobacterial
isolates. This is another conﬁrmation that ISApl1 may be found in
Moraxella spp. after its identiﬁcation in the genome of M. porci.
Notably, the concomitant identiﬁcation of IS1595 and of anmcr-2-
like gene in the same M. pluranimalium strain further suggests
that the mobilization event that led to the further dissemination
of mcr-2 in Enterobacteriaceae had ﬁrst occurred from
M. pluranimalium.
This report most likely identiﬁes the direct progenitor of the
mcr-2 gene asM. pluranimalium, aboutwhich little is known so far.
Strains belonging to this species have been recovered from pigs
that were either healthy or suffering from pleuritis and polyserosi-
tis (nose, pleura and peritoneal cavity ﬂuids), and from the brain of
a sheep presenting with meningitis. It is likely that pigs might con-
stitute a signiﬁcant reservoir of M. pluranimalium. We speculate
that the occurrence, selection, mobilization and dissemination of
mcr-like genes might have occurred ﬁrst in pigs. Since colistin is
widely prescribed in veterinary medicine, in particular in pig farms,
it represents a driving force for selection and spread of naturally
occurring mcr-like resistance genes from Moraxella to
Enterobacteriaceae. The present report paves the way for rethink-
ing antibiotic policy in veterinary medicine, since this is likely a sig-
niﬁcant driving force for selection of antibiotic resistance traits that
may have signiﬁcant impacts in human medicine, as previously
hypothesized.10
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